Express Scripts' yearly Drug Trend Report found that the cost of brand-name treatments rose 12.5% in 2012, far faster than the 1.7% overall inflation rate in the U.S. The report said the cost of an unchanged selection of brand-name drugs increased from $100 to $165.44 between January 2008 to December 2012.

Related Summaries